Major COPD Breakthrough Offers Hope for Millions Worldwide AstraZeneca's Tozorakimab Shows Highly Significant Results in Phase 3 Trials After years of failed attempts by competitors, AstraZeneca has achieved a breakthrough in treating chronic obstructive pulmonary disease (COPD) — the world's third leading cause of death. The company&